The targeted behavior of folate-decorated N-succinyl-N′-octyl chitosan evaluated by NIR system in mouse model

被引:1
|
作者
Zhu, Hongyan [1 ,2 ]
Deng, Dawei [1 ]
Chen, Haiyan [1 ]
Qian, Zhiyu [3 ]
Gu, Yueqing [1 ]
机构
[1] China Pharmaceut Univ, Sch Life Sci & Technol, Dept Biomed Engn, Nanjing 210009, Peoples R China
[2] Nantong Univ, Coll Med, Dept Pharmacol, Nantong 226001, Peoples R China
[3] Nanjing Univ Aeronaut & Astronaut, Sch Automat, Dept Biomed Engn, Nanjing, Jiangsu 210016, Peoples R China
关键词
folate; near infrared fluorescence imaging; tumor; nanoparticles; chitosan; NEAR-INFRARED SPECTROSCOPY; IN-VIVO; DRUG-DELIVERY; LIPOSOMAL DOXORUBICIN; ANTITUMOR-ACTIVITY; OVARIAN-CANCER; PHARMACOKINETICS; NANOCARRIERS; EFFICIENT; COPOLYMER;
D O I
10.1117/12.870163
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The development of more selective delivery systems for cancer diagnosis and chemotherapy is one of the most important goals of current anticancer research. The purpose of this study is to construct and evaluate the folate-decorated, self-assembled nanoparticles as candidates to deliver near infrared fluorescent dyes into tumors and to investigate the mechanisms underlying the tumor targeting with folate-decorated, self-assembled nanoparticles. Folate-decorated N-succinyl-N'-octyl chitosan (folate-SOC) were synthesized. The chemical modification chitosan could self-assemble into stable micelles in aqueous medium. Micelle size determined by size analysis was around 140 nm in a phosphate-buffered saline (PBS, PH 7.4). Folate-SOC could maintain their structure for up to 15 days in PBS. Near infrared dye ICG-Der-01 as a mode drug was loaded in the micelles, and the entrapment efficiency (EE) and drug loading (DL) were investigated. The targeted behavior of folate-SOC was evaluated by near-infrared fluorescence imaging in vivo on different groups of denuded mice, with A549 or Bel-7402 tumors. The optical imaging results indicated that folated-decorated SOC showed an excellent tumor specificity in Bel-7402 tumor-bearing mice, and weak tumor specificity in A549 tumor bearing mice. We believe that this work can provide insight for the engineering of nanoparticles and be extended to cancer therapy and diagnosis so as to deliver multiple therapeutic agents and imaging probes at high local concentrations.
引用
收藏
页数:10
相关论文
共 6 条
  • [1] Preparation and characterization of N-succinyl-N′-octyl chitosan micelles as doxorubicin carriers for effective anti-tumor activity
    Xu Xiangyang
    Li Ling
    Zhou Hanping
    Lu Shiyue
    Yang He
    Yin Xiaojin
    Ren Jinsheng
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2007, 55 (02) : 222 - 228
  • [2] The targeted behavior of thermally responsive nanohydrogel evaluated by NIR system in mouse model
    Zhang, Jian
    Chen, Haiyan
    Xu, Lin
    Gu, Yueqing
    JOURNAL OF CONTROLLED RELEASE, 2008, 131 (01) : 34 - 40
  • [3] Enhanced tumor targeting and antitumor efficacy via hydroxycamptothecin-encapsulated folate-modified N-succinyl-N-octyl chitosan micelles
    Zhu, Hongyan
    Cao, Jie
    Cui, Sisi
    Qian, Zhiyu
    Gu, Yueqing
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 102 (04) : 1318 - 1332
  • [4] The Targeting Behavior of Folate-Nanohydrogel Evaluated by Near Infrared Imaging System in Tumor-Bearing Mouse Model
    Zhang, Jian
    Deng, Dawei
    Qian, Zhiyu
    Liu, Fei
    Chen, Xinyang
    An, Lianxiao
    Gu, Yueqing
    PHARMACEUTICAL RESEARCH, 2010, 27 (01) : 46 - 55
  • [5] The Targeting Behavior of Folate-Nanohydrogel Evaluated by Near Infrared Imaging System in Tumor-Bearing Mouse Model
    Jian Zhang
    Dawei Deng
    Zhiyu Qian
    Fei Liu
    Xinyang Chen
    Lianxiao An
    Yueqing Gu
    Pharmaceutical Research, 2010, 27 : 46 - 55
  • [6] The protective effect of Boswellic acid and Ellagic acid loaded, colon targeted, and pH-sensitive N-succinyl chitosan in ulcerative colitis rat model
    Yipel, Mustafa
    Tekeli, Ibrahim Ozan
    Altinok-Yipel, Fulya
    Coskun, Pinar
    Aslan, Abdullah
    Guvenc, Mehmet
    Beyazit, Neslihan
    Ozsoy, Sule Yurdagul
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2022, 68